This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels, Belgium; 2021. [ https://www.diabetesatlas.org] (access: 26.02.2023).Search in Google Scholar
Zatońska K, Basiak-Rasała A, Różańska D, Karczewski M, Wołyniec M, Szuba A, et al. Changes in diabetes prevalence and corresponding risk factors – findings from 3- and 6-year follow-up of PURE Poland cohort study. BMC Public Health. 2020;20:843.Search in Google Scholar
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes – 2021. Diabetes Care. 2021;44:15-33.Search in Google Scholar
Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, et. al. The association between diabetes mellitus and incident infections: a systematic review and meta-Analysis of observational studies. BMJ Open Diabetes Res Care. 2017;5:e000336.Search in Google Scholar
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27-36.Search in Google Scholar
Dworzański J, Drop B, Kliszczewska E, Strycharz-Dudziak M, Polz-Dacewicz M. Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland. PLoS One, 2019;14:e0222607.Search in Google Scholar
Weekly Epidemiological Update on COVID-19 – 1 September 2023. Edition 158. World Health Organization. [https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-1-september-2023] (access: 12.09.2023).Search in Google Scholar
McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: A cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021;9:82-93.Search in Google Scholar
Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, et al. Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms. 2021;9:1211.Search in Google Scholar
Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:210123.Search in Google Scholar
Vergara-Alert J, Izquierdo-Useros N. An anti-SARS-CoV-2 metabolite is reduced in diabetes. Nat Metab. 2022l;4:501-2.Search in Google Scholar
Al-Aly Z. Diabetes after SARS-CoV-2 Infection. Lancet Diabetes Endocrinol. 2023;11:11-3.Search in Google Scholar
Chandrashekhar Joshi S, Pozzilli P. COVID-19 Induced Diabetes: A Novel Presentation. Diabetes Res Clin Pract. 2022; 191: 110034.Search in Google Scholar
Pal R, Bhadada SK, Misra A. COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021;15:505-8.Search in Google Scholar
Zhou T, Hu Z, Yang S, Sun L, Yu Z, Wang G. Role of adaptive and innate immunity in type 2 diabetes mellitus. J Diabetes Res. 2018; 2018:7457269.Search in Google Scholar
Qiao YC, Shen J, He L, Hong XZ, Tian F, Pan YH, et al. Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res. 2016;2016:3694957.Search in Google Scholar
Han M, Ma K, Wang X, Yan W, Wang H, You J, et al. Immunological characteristics in type 2 diabetes mellitus among COVID-19 patients. Front Endocrinol. 2021;12:596518.Search in Google Scholar
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 2020;11:1582.Search in Google Scholar
Van Praet JT, Vandecasteele S, De Roo A, Vynck M, De Vriese AS, Reynders M. Dynamics of the cellular and humoral immune response after BNT162b2 messenger ribonucleic acid coronavirus disease 2019 (COVID-19) vaccination in COVID-19-naive nursing home residents. J Infect Dis. 2021;224:1690-3.Search in Google Scholar
Sauré D, O’Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. 2022;22:56-63.Search in Google Scholar
Rego GNA, Nucci MP, Alves AH, Oliveira FA, Marti LC, Nucci LP, et al. Current clinical trials protocols and the global effort for immunization against SARS-CoV-2. Vaccines (Basel). 2020;8:474.Search in Google Scholar
Ali H, Alterki A, Sindhu S, Alahmad B, Hammad M, Al-Sabah S, et al. Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 MRNA COVID-19 vaccination. Front. Immunol. 2021;12:752233.Search in Google Scholar
Sourij C, Tripolt NJ, Aziz F, Aberer F, Forstner P, Obermayer AM, et al. Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study. Diabetes Obes Metab. 2022;24:849-58.Search in Google Scholar
Nomura Y, Sawahata M, Nakamura Y, Kurihara M, Koike R, Katsube O, et al. Age and smoking predict antibody titres at 3 Months after the second dose of the BNT162b2 COVID-19 vaccine. Vaccines. 2021; 9:1042.Search in Google Scholar
Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021;9:999-1009.Search in Google Scholar
Virgilio E, Trevisan C, Abbatecola A, Malara A, Palmieri A, Fedele G, et al. Diabetes affects antibody response to SARS-CoV-2 vaccination in older residents of long-term care facilities: Data from the GeroCovid vax study. Diabetes Care. 2022;45:2935-42.Search in Google Scholar
Heinz FX, Stiasny K. Distinguishing Features of Current COVID-19 Vaccines: Knowns and unknowns of antigen presentation and modes of action. NJP Vaccines. 2021;6:104.Search in Google Scholar
Age-adjusted percentage of obesity for adults with diabetes, United States, 1994-2007. Available from: http://www.cdc.gov/diabetes/statistics/comp/fig7_obesity.htm Accessed 30 March 2023.Search in Google Scholar
Frasca D, Ferracci F, Diaz A, Romero M, Lechner S, Blomberg BB. Obesity decreases B cell responses in young and elderly individuals. Obesity. 2016;24:615-25.Search in Google Scholar
Frasca D, Reidy L, Cray C, Diaz A, Romero M, Kahl K, et al. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PLoS ONE. 2021;16:e0245424.Search in Google Scholar
Notarte KI, Ver AT, Velasco JV, Pastrana A, Catahay JA, Salvagno GL, et al. Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review. Crit Rev Clin Lab Sci. 2022;59:373-90.Search in Google Scholar
Soegiarto G, Wulandari L, Purnomosari D, Dhia Fahmita K, Ikhwan Gautama H, Tri Hadmoko S, et al. Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2. Vaccine. 2022;40:4046-56.Search in Google Scholar
Zhai X, Qian G, Wang Y, Chen X, Lu J, Zhang Y, et al. Elevated B Cell Activation is associated with type 2 diabetes development in obese subjects. Cell Physiol Biochem. 2016;38:1257-66.Search in Google Scholar
Marfella R, Sardu C, D’Onofrio N, Prattichizzo F, Scisciola L, Messina V, et al. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nat Commun. 2022;13:2318.Search in Google Scholar
Cheng Y, Shen P, Tao Y, Zhang W, Xu B, Bi Y, et al. Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals. Front Public Health. 2022;10:1025901.Search in Google Scholar
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical Recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546-50.Search in Google Scholar
Tan CM, Chia WN, Qin X, Liu P, Chen MI-C, Tiu C, et al. A SARSCoV-2 surrogate virus neutralization test (sVNT) based on antibody mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020;38:1073-8.Search in Google Scholar
Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P, et al. Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review. Front Immunol. 2022; 13:940357.Search in Google Scholar